Tag:
osteoperosis
Latest Headlines
Latest Headlines
Radius $86M IPO to propel bone-growing injection drug, microneedle patch
Radius Health, which is testing injectable and microneedle patch versions of its lead osteoporosis drug, filed plans Feb. 6 to dive into the public markets. The IPO is ambitious for life sciences...
Unigene regains treatment rights as GSK backs out
Unigene Laboratories ( $UGNE ) says it has regained the global rights to an oral formulation of a parathyroid hormone analog to treat osteoporosis in postmenopausal women from GlaxoSmithKline ( $GSK ).
Novartis falls short in trial for oral osteoporosis drug
Novartis Pharma's ( $NVS ) oral formulation of calcitonin to treat for post-menopausal osteoporosis failed to meet its primary endpoint or key secondary endpoints in a crucial critical trial....
